Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

369 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
ABSORB bioresorbable vascular scaffold vs. everolimus-eluting metallic stent in ST-segment elevation myocardial infarction (BVS EXAMINATION study): 2-Year results from a propensity score matched comparison.
Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Ortega-Paz L, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Giacchi G, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M. Brugaletta S, et al. Among authors: cequier a. Int J Cardiol. 2016 Jul 1;214:483-4. doi: 10.1016/j.ijcard.2016.04.016. Epub 2016 Apr 7. Int J Cardiol. 2016. PMID: 27096965 No abstract available.
Predictors and clinical implications of stent thrombosis in patients with ST-segment elevation myocardial infarction: Insights from the EXAMINATION trial.
Brugaletta S, Sabate M, Martin-Yuste V, Masotti M, Shiratori Y, Alvarez-Contreras L, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Gomez-Lara J, Backx B, Serruys PW. Brugaletta S, et al. Among authors: cequier a. Int J Cardiol. 2013 Oct 3;168(3):2632-6. doi: 10.1016/j.ijcard.2013.03.036. Epub 2013 Apr 8. Int J Cardiol. 2013. PMID: 23578890 Clinical Trial.
Everolimus-eluting stent versus bare-metal stent in elderly (≥75 years) versus non-elderly (<75 years) patients with ST-elevation myocardial infarction undergoing primary percutaneous coronary intervention: insights from the examination trial.
Ielasi A, Brugaletta S, Silvestro A, Cequier A, Iñiguez A, Serra A, Hernandez-Antolin R, Mainar V, Valgimigli M, den Heijer P, Bethencourt A, Vazquez N, Serruys P, Sabate M, Tespili M. Ielasi A, et al. Among authors: cequier a. Int J Cardiol. 2015 Jan 20;179:73-8. doi: 10.1016/j.ijcard.2014.10.038. Epub 2014 Oct 22. Int J Cardiol. 2015. PMID: 25464418 Clinical Trial.
Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
Brugaletta S, Gori T, Low AF, Tousek P, Pinar E, Gomez-Lara J, Scalone G, Schulz E, Chan MY, Kocka V, Hurtado J, Gomez-Hospital JA, Münzel T, Lee CH, Cequier A, Valdés M, Widimsky P, Serruys PW, Sabaté M. Brugaletta S, et al. Among authors: cequier a. JACC Cardiovasc Interv. 2015 Jan;8(1 Pt B):189-197. doi: 10.1016/j.jcin.2014.10.005. JACC Cardiovasc Interv. 2015. PMID: 25616924 Free article.
Impact of stent overlapping on long-term clinical outcomes in patients with ST-segment elevation myocardial infarction: insights from the five-year follow-up of the EXAMINATION trial.
Ortega-Paz L, Brugaletta S, Giacchi G, Ishida K, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Valgimigli M, Serruys PW, Sabaté M. Ortega-Paz L, et al. Among authors: cequier a. EuroIntervention. 2017 Aug 4;13(5):e557-e563. doi: 10.4244/EIJ-D-16-00512. EuroIntervention. 2017. PMID: 28242584 Free article.
Impact of Body Mass Index on 5-Year Clinical Outcomes in Patients With ST-Segment Elevation Myocardial Infarction After Everolimus-Eluting or Bare-Metal Stent Implantation.
Moscarella E, Spitaleri G, Brugaletta S, Sentí Farrarons S, Pernigotti A, Ortega-Paz L, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M. Moscarella E, et al. Among authors: cequier a. Am J Cardiol. 2017 Nov 1;120(9):1460-1466. doi: 10.1016/j.amjcard.2017.07.040. Epub 2017 Jul 31. Am J Cardiol. 2017. PMID: 28864322 Clinical Trial.
Correlates of non-target vessel-related adverse events in patients with ST-segment elevation myocardial infarction: insights from five-year follow-up of the EXAMINATION trial.
Spitaleri G, Moscarella E, Brugaletta S, Pernigotti A, Ortega-Paz L, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M. Spitaleri G, et al. Among authors: cequier a. EuroIntervention. 2018 Mar 20;13(16):1939-1945. doi: 10.4244/EIJ-D-17-00608. EuroIntervention. 2018. PMID: 29260713 Free article. Clinical Trial.
Role of ST-Segment Resolution in Patients With ST-Segment Elevation Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention (from the 5-Year Outcomes of the EXAMINATION [Evaluation of the Xience-V Stent in Acute Myocardial Infarction] Trial).
Spitaleri G, Brugaletta S, Scalone G, Moscarella E, Ortega-Paz L, Pernigotti A, Gomez-Lara J, Cequier A, Iñiguez A, Serra A, Jiménez-Quevedo P, Mainar V, Campo G, Tespili M, den Heijer P, Bethencourt A, Vazquez N, Valgimigli M, Serruys PW, Sabaté M. Spitaleri G, et al. Among authors: cequier a. Am J Cardiol. 2018 May 1;121(9):1039-1045. doi: 10.1016/j.amjcard.2018.01.015. Epub 2018 Feb 7. Am J Cardiol. 2018. PMID: 29544865
Three-year follow-up of the randomised comparison between an everolimus-eluting bioresorbable scaffold and a durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction (TROFI II trial).
Katagiri Y, Onuma Y, Asano T, Iñiguez A, Jensen LO, Cequier À, Hofma SH, Christiansen EH, Suttorp M, Brugaletta S, Räber L, Sabaté M, Windecker S, Serruys PW. Katagiri Y, et al. Among authors: cequier a. EuroIntervention. 2018 Dec 7;14(11):e1224-e1226. doi: 10.4244/EIJ-D-18-00839. EuroIntervention. 2018. PMID: 30398967 Free article. Clinical Trial. No abstract available.
Bioresorbable vascular scaffolds versus everolimus-eluting metallic stents in patients with ST-segment elevation myocardial infarction: 5-year results of the BVS-EXAMINATION study.
Brugaletta S, Gori T, Tousek P, Gomez-Lara J, Pinar E, Ortega-Paz L, Schulz E, Kocka V, Münzel T, Cequier À, Buono A, Serruys PW, Sabaté M; Collaborators. Brugaletta S, et al. Among authors: cequier a. EuroIntervention. 2020 Mar 20;15(16):1436-1443. doi: 10.4244/EIJ-D-19-00773. EuroIntervention. 2020. PMID: 31845896 Free article.
369 results